Search for: "U.S. Pharmaceutical Corporation"
Results 61 - 80
of 1,601
Sorted by Relevance
|
Sort by Date
24 Jul 2007, 9:51 am
The article says that Eli Lilly paid only about 6 percent in U.S. federal taxes on its profits of around three and a half billion dollars last year.Part of the problem is that many large corporations manipulate "transfer pricing" which is basically the accounting that must take place when divisions of a corporation that are based in different countries "sell" and "buy" products or services to and from each other. [read post]
2 Apr 2012, 11:56 am
On March 26, 2012, the U.S. [read post]
25 Jan 2016, 10:29 am
In effect, the U.S. [read post]
23 May 2010, 9:52 pm
May 24-25, 2010 - Hatch-Waxman Boot Camp*** (American Conference Institute) - San Diego, CA May 24-26, 2010 - Pharmaceutical & Biotech Patent Litigation Strategies*** (Pharma IQ) - London, England May 25, 2010 - "The Gene Uncertainty: What to Do After Myriad" (Intellectual Property Owners Association) - 2:00 PM (EST) May 25, 2010 - Corporate Intellectual Property Law Conference (Law Bulletin) - Chicago, IL May 26-27, 2010 - 7th International Forum on Freedom to… [read post]
6 Feb 2015, 12:36 pm
("Daiichi"), a U.S. subsidiary of a Japanese pharmaceutical company, agreed to pay $39 million to settle alleged violations of the Anti-Kickback Statute and False Claims Act ("FCA"). [read post]
21 Nov 2006, 12:04 pm
Novartis Pharmaceuticals Corporation, No. 05-CV-5350, and was filed in the U.S. [read post]
23 Nov 2011, 6:23 am
§ 78m, which require corporations to (1) make and keep books and records that accurately and fairly reflect the transactions of the corporation and (2) devise and maintain an adequate system of internal accounting controls. [read post]
8 Jan 2014, 12:59 pm
Tom Coburn (R-OK) introduced legislation to “force enforcement agencies to provide more details about deals to resolve corporate misconduct by U.S. companies. [read post]
29 Sep 2014, 8:00 am
Shire has also entered into a corporate integrity agreement with the U.S. [read post]
10 Sep 2020, 6:35 am
Agreements among competitors to defer competition, however, could be unlawful under U.S. antitrust laws and competition laws of other countries. [read post]
6 May 2018, 4:15 am
Cordis Corporation et. al. which vacated and remanded a lower court’s ruling that claims of patent infringement alleged by Israeli pharmaceutical firm Medinol were barred by the equitable defense of laches. [read post]
2 Mar 2008, 7:26 pm
March 12, 2008 - Biotechnology, Chemical & Pharmaceutical Art Group Customer Partnership Meeting (U.S. [read post]
14 Jun 2019, 12:24 pm
LSI Corporation and Avago Technologies U.S. [read post]
2 Mar 2008, 7:26 pm
March 12, 2008 - Biotechnology, Chemical & Pharmaceutical Art Group Customer Partnership Meeting (U.S. [read post]
12 Mar 2009, 9:59 pm
See AP's "Roche to take over Genentech": GENEVA (March 12)--Swiss pharmaceutical giant Roche agreed to pay $46.8 billion to buy the 44 percent of biotech pioneer Genentech that it doesn't already own, ending a long corporate struggle with its U.S. [read post]
9 Mar 2008, 7:15 pm
March 12, 2008 - Biotechnology, Chemical & Pharmaceutical Art Group Customer Partnership Meeting (U.S. [read post]
18 Jul 2011, 6:47 am
I use the number of scientists on the board of directors as a proxy for the board’s intellectual capital and investigate the impact of directors-scientists on firm value in the population of publicly-listed U.S. firms. [read post]
7 Oct 2015, 12:35 pm
It is written to expose the dangers that countries face, especially low- and middle-income countries, in trade negotiations with the U.S., Europe, and Japan that seek to impose stronger patent, data, and market entry protections and at the same time seek to expand the armamentarium of enforcement powers available to pharmaceutical behemoths. [read post]
27 May 2011, 7:20 am
On May 10, 2011, the U.S. [read post]
9 Apr 2009, 9:14 pm
District Court for the District of Delaware has ruled that Watson Pharmaceuticals, Inc.'s generic version of Concerta ® (methylphenidate hydrochloride extended-release tablets) does not infringe ALZA Corporation's and McNeill-PPC's patent covering the drug. [read post]
